Search results for

The Indianapolis-based drugmaker said Monday that it would offer a generic version of Humalog insulin, one of its best-selling medicines. The move could help blunt criticism about high prices.

Well-known insurers are selling new sorts of health plans outside the Affordable Care Act exchanges that may sound cheaper but aren't necessarily. Some, for example, charge extra for common surgeries.

The 5 recipients of the Skoll Awards for Social Entrepreneurship predict how their projects will make the world a better place.

At the midpoint of his four-year term, President Trump has delivered on some campaign promises and ignored others, while many are still works in progress.

Apps can make managing health care a lot easier, but most don't have the privacy protections required of doctors and hospitals. And a simple Web search can clue in advertisers to health concerns.

Conservatives are revolting against the GOP health care measure. David Greene talks to David Urban, president of American Continental Group, and a former adviser to the Trump presidential campaign.

When a new drug is up for FDA approval, trials may be held not only in the U.S. but other countries too. A study looks at global availability after approval. Big Pharma disagrees with the findings.

Customers want to read reviews and businesses need reviews to attract customers. But the constant demand for reviews could be creating a feedback backlash, experts say.

On new albums by viral sensation Yebba and studio whiz Pimmie, it's clear modern R&B has been clearing space for vastly different stripes of singer-songwriter.

NPR's Audie Cornish speaks with author Dave Eggers about his new book, The Every, a dystopian look at the near-future when one massive company controls just about everything.